Trimi Health

Trimi Health review

A clear monthly baseline with materially different prepaid terms. The costs, commitments and questions worth considering.

GLP1 Rank is a commercial comparison site. We may earn a commission through links. How we’re funded

Our take

Trimi gives unusually clear answers about the cash due and which plans renew. I would start with the $175 monthly baseline, then judge the prepaid discount against the prescription-stage refund cutoff.

Reasons to look closer

  • Explicit upfront totals
  • Named care network and dispensing pharmacy
  • Different renewal rules clearly stated

Keep in mind

The $99 headline is a twelve-month equivalent, not a monthly installment. A prescription being issued generally ends the ordinary refund window.

The costs at a glance

Published price reference$175/month
Standard monthly compounded semaglutide plan
MedicationCompounded semaglutide; standard tirzepatide priced separately
CommitmentMonthly and quarterly renew automatically; six-month and annual do not
Important contextAnnual equivalent $99/month requires $1,188 upfront; quarterly $435 and six-month $720. Sale enrollment has separate terms.

Begin with the short plan, then price the discount

The standard semaglutide page offers a genuine monthly baseline: $175 billed each month. The quarterly choice costs $435 upfront, the six-month choice $720, and the annual choice $1,188. Their displayed monthly equivalents are $145, $120 and $99 respectively. I find this a more useful starting point than treating the smallest headline as the normal monthly bill. The annual discount purchases a longer commitment as well as a lower average. Before prepaying, ask how much flexibility you would need if the clinician changes the prescription, your circumstances change, or the service is a poor fit. Read our prepaid-plan calculator for the next questions to work through.

Renewal works differently across the plan ladder

Trimi distinguishes the two shorter subscriptions from the longer prepaid terms. Monthly and quarterly plans renew automatically unless renewal is switched off. Six-month and annual plans do not; continuing requires a provider check-in and a new decision about the next term. That distinction reduces the risk of an unnoticed second annual purchase, but it does not make the first annual payment refundable on demand. I would save the selected term and its end date alongside the amount charged. A nonrenewing commitment can still be a substantial commitment, particularly when you have not yet established how treatment fits your medical needs.

Do not combine standard pricing with sale terms

The program terms identify a separate sale enrollment pathway. That offer uses its own checkout pricing, has monthly and three-month choices, and excludes the standard six-month and annual options. Its shipping service also differs from the standard program. I would compare the actual enrollment screen with the plan being discussed before accepting an advertised saving. A reader should not combine the standard annual rate with a sale promise from another pathway. Existing customers also retain the price and term they purchased; a later lower offer does not automatically create a credit, refund or migration to the new price.

The refund boundary comes before delivery

Payment is collected before the medical assessment, with a full refund when the clinician finds treatment unsuitable. The refund policy generally permits cancellation before a prescription is issued, then treats the prescription purchase as final even if the package has not shipped. That is a more important boundary than the tracking email. I would finish comparing providers before paying and ask support immediately if reconsidering an order. Turning off a future renewal is a different action from requesting money back for the term already purchased. A prepaid plan should be assessed with this prescription-stage restriction in view. Read our cancellation and refund guide for the next questions to work through.

Read the six-month promise as a conditional policy

Trimi's money-back policy has conditions, including completing six continuous months, following the prescribed plan, recording starting and six-month weights, and showing no net weight loss. A request must fall within the stated thirty-day window after that point. It is not a promise that an early voluntary stop produces a refund, nor evidence that everyone will respond to treatment. The policy separately allows review of a written clinician-directed stop for unused treatment. I would retain the applicable policy and ask how the documentation is submitted. A conditional commercial protection should not influence a medical decision to continue or stop treatment.

Named partners make the next questions more concrete

The treatment page identifies Arora Health as the medical network and BelieveRx, formerly VialsRx, as the dispensing pharmacy. It also publishes a Texas pharmacy license number. These are useful details to investigate; they are not an independent license inspection by GLP1 Rank. Ask which clinician and pharmacy will actually serve the order, particularly if the arrangement changes. Trimi describes compounded prescriptions, which do not receive FDA approval as finished medicines. I would keep a quality or licensing claim separate from a claim that the specific drug has the same evidence as an approved product. Read our pharmacy verification guide for the next questions to work through.

Overnight shipping starts after pharmacy preparation

The standard program describes overnight delivery once the medication has been compounded. Intake, clinician review and preparation come first, so this is not a promise of delivery the day after signing up. The refund policy also asks for damage or missing-item reports within twenty-four hours of the delivery scan. I would inspect the package promptly and retain photographs if something is wrong. For a refrigerated medicine arriving warm or inadequately cooled, the policy directs patients not to use it and to contact the pharmacy. The clinical team and pharmacist should resolve a product concern before an injection is attempted.

My assessment: clarity is the attraction, prepayment is the trade-off

Trimi is worth a close comparison for readers who value an explicit price ladder and clear renewal distinctions. Medication, supplies, provider access and shipping are included in the standard offer, while clinical approval remains individual. My reservation is not that the annual arithmetic is hidden; it is that a visible discount can distract from the amount at risk after the prescription is issued. Compare Amble for another term-based model or CoreAge RX for another reviewed direct-pay option, matching the actual prescription and care. The right starting comparison is the complete short-plan purchase, followed by a deliberate decision about longer terms.

Before you sign up

  • Am I enrolling in the standard program or a separate sale offer?
  • What happens to unused prepaid treatment after a clinician-directed stop?
  • What exact stage ends my ordinary cancellation right?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.

Compare the complete budget · Save your provider checklist

Research the questions behind this offer

Other providers to compare

Compare another direct-pay model with term-specific obligations.

Amble

A short-plan price with longer-term tradeoffs

Amble

$179/advertised month

One-month compounded GLP-1 plan reference

Named prescription and checkout control. Six-month tables conflict ($135 versus $145 monthly equivalent); bulk terms are prepaid and refunds depend on pharmacy transmission.

Compare a reviewed medication package and its price scope.

CoreAge

Compounded treatment without a membership fee

CoreAge Rx

$79/month

Advertised semaglutide starting price

Product and homepage offers show $79, while navigation says $99. Confirm the selected checkout price; FAQ and refund terms differ on fees and renewals.

One more option